Donate today to support osteosarcoma research in honor of Cole Bright.


Cole’s Story

Cole Bright was living his life like any normal 10-year-old. He played sports and video games. His life was turned upside down on October 21, 2022 when he was diagnosed with osteosarcoma. What looked like a small fracture on an X-ray was actually a bone tumor. The rigor of chemotherapy began the following week. On February 2, 2023, a team of three surgeons removed the tumor in the right distal radius and reconstructed his wrist salvaging the limb. After the surgery, he endured five more months of chemotherapy. Cole’s mom, Sarah, shares, “As of July 19, 2023, Cole is in remission. While we don’t know what the future holds, we do know that a 1 in 3 survival rate isn’t good enough. We know that no new medical advances in 40 years isn’t good enough. We hope that Cole’s journey spreads awareness for osteosarcoma and with your support we can find a cure.”


About the Osteosarcoma Institute

The mission of the Osteosarcoma Institute (OSI) is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science. To date, the OSI has committed over $5.2 million to promising osteosarcoma research in the following areas:

  • Clinical trials of new potential therapies that have promising preclinical rationales
  • Correlative studies that evaluate how and why a potential new therapy works, or doesn’t work, in clinical trials
  • Translational studies that investigates the basic biology of osteosarcoma and its metastasis and looks for clues for how to attack it

Osteosarcoma Statistics

bone icon

Osteosarcoma is the most common childhood bone cancer.

microscope icon

No new treatments have been approved for osteosarcoma patients in 40 years.

ribbon icon

1 in 3 children with osteosarcoma will not survive.

Frequently Asked Questions

  • image/svg+xmlimage/svg+xml
    What is osteosarcoma?

    Osteosarcoma is a type of bone cancer that originates in cells of the bone. The word “osteosarcoma” comes from the Greek words sarc, meaning fleshy substance, and oma, meaning growth. Osteo adds bone-like to the word sarcoma. It can occur anywhere along the skeleton, but the most common sites are in longer bones, for instance around the knee (distal femur and proximal tibia) and shoulder (proximal humerus).

  • image/svg+xmlimage/svg+xml
    How common is osteosarcoma?

    Osteosarcoma is rare — only around 1,000 people are diagnosed in the United States each year. Osteosarcoma most commonly occurs in children, teenagers and young adults between the ages of 10 and 30. It is slightly more common in boys and young men. There is a peak incidence of osteosarcoma during the adolescent growth spurt. It is very rare in children under 5 years old.

  • image/svg+xmlimage/svg+xml
    What causes osteosarcoma?

    The exact cause is still unknown. Osteosarcoma develops when healthy cells responsible for making new bone experience changes in their DNA. These DNA changes tell the cells to make abnormal bone. This results in a tumor that invades and destroys surrounding healthy bone and surrounding tissue.

  • image/svg+xmlimage/svg+xml
    Can osteosarcoma be prevented?

    It cannot be prevented. However, there are certain risk factors to be aware of. Osteosarcoma risk factors include:
    ● Bone disorders (Paget’s disease and fibrous dysplasia)
    ● Exposure to radiation (for example, previous cancer treatment)
    ● Rare, inherited disorders (hereditary retinoblastoma, Bloom syndrome, Li-Fraumeni syndrome, Rothmund-Thomson syndrome and Werner syndrome)

  • image/svg+xmlimage/svg+xml
    What are the symptoms?

    People with osteosarcoma may have a variety of symptoms, including:
    ● Pain in and around a bone that becomes persistent and severe over time
    ● Swelling near a bone
    ● Limping and/or inability to lift or use a limb
    ● Bone injury/fracture from minor trauma
    If you or your child is experiencing any of the above symptoms, contact your doctor.

  • image/svg+xmlimage/svg+xml
    How is osteosarcoma diagnosed?

    The diagnosis of osteosarcoma can only be definitively made with a biopsy of the affected area. Thanks to advanced imaging technology, doctors can see — with precision — where the abnormality is located in the body and help guide the biopsy. Once a biopsy confirms the diagnosis of osteosarcoma, a variety of other tests may be ordered to further determine the extent of the tumor. These may include:
    ● X-Ray
    ● Computed tomography (CT) scan
    ● Magnetic resonance imaging (MRI)
    ● Positron emission tomography (PET) scan
    ● Additional blood tests

  • image/svg+xmlimage/svg+xml
    Can osteosarcoma spread?

    Yes, osteosarcoma can metastasize, or spread, to other areas of the body, most commonly to the lungs. Osteosarcoma that spreads to the lungs happens when tumor cells travel to the lungs through the bloodstream. But since our blood always travels to the lungs to provide oxygen to our blood (and not all cancers spread to the lungs first), there must be additional reasons that osteosarcoma is so prone to lung metastases. This is an area of active research.

  • image/svg+xmlimage/svg+xml
    What are the treatment options for osteosarcoma?

    Current therapy for osteosarcoma almost always includes the combination of a standard chemotherapy treatment and surgery. Most commonly, chemotherapy is given for several months before surgery and is continued after the patient has recovered from their surgery. The type of surgery performed can vary, but usually includes limb-preservation surgery. Following recovery from surgery, patients begin physical rehabilitation as part of their recovery process.

  • image/svg+xmlimage/svg+xml
    What should I know about clinical trials?

    Clinical trials are available, if and when a patient recurs, following standard treatment. These trials provide patients access to novel treatment methods and drug therapies that are being developed to treat osteosarcoma. Depending on your individual case, you may be eligible to participate in one. The Osteosarcoma Institute is pleased to connect you with a free and confidential clinical trial matching service. Most clinical trials for osteosarcoma include newer “targeted therapy drug” or combinations with immunotherapy.

  • image/svg+xmlimage/svg+xml
    What are treatment side effects?

    With any cancer treatment, there are side effects. This is also true for osteosarcoma treatment. Surgery often involves use of an internal prosthesis and rarely an external prosthesis. Physical therapy will be provided as you heal to help guide rehabilitation and ensure strength and movement are regained in the safest way possible. Chemotherapy side effects can include hair loss, nausea, fatigue, weakness, loss of appetite and weight loss. These side effects will resolve when chemotherapy is completed.

  • image/svg+xmlimage/svg+xml
    What is the outlook for people with osteosarcoma?

    The outlook depends on many factors, including the location and size of the tumor, whether the cancer has spread and the person’s age and overall health. For more information on osteosarcoma survival rates, click here.

  • image/svg+xmlimage/svg+xml
    Why is more research needed?

    There have been no improvements in survival of osteosarcoma patients for more than 30 years. Osteosarcoma is complex, and more research is needed. For a brief history of osteosarcoma treatment, click here. Areas of research include gene therapy, targeted drug therapy and immunotherapy.

Translate »